These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17552245)
1. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)]. Zhao ZP; Xia XZ; Hu RL; Xie ZJ; Yan F; Huang G; Yang ST Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245 [TBL] [Abstract][Full Text] [Related]
2. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus]. Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263 [TBL] [Abstract][Full Text] [Related]
3. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines. Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013 [TBL] [Abstract][Full Text] [Related]
4. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327 [TBL] [Abstract][Full Text] [Related]
5. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Hu R; Zhang S; Fooks AR; Yuan H; Liu Y; Li H; Tu C; Xia X; Xiao Y Microbes Infect; 2006 Apr; 8(4):1090-7. PubMed ID: 16524754 [TBL] [Abstract][Full Text] [Related]
6. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027 [TBL] [Abstract][Full Text] [Related]
7. [Construction of recombinant canine adenovirus type 2 expressing Canine coronavirus spike glycoprotein and its immunogenicity]. Qiao J; Xia XZ; Yang ST; Hu GX; Xie ZJ Wei Sheng Wu Xue Bao; 2005 Aug; 45(4):588-92. PubMed ID: 16245877 [TBL] [Abstract][Full Text] [Related]
8. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Henderson H; Jackson F; Bean K; Panasuk B; Niezgoda M; Slate D; Li J; Dietzschold B; Mattis J; Rupprecht CE Vaccine; 2009 Nov; 27(51):7194-7. PubMed ID: 19925952 [TBL] [Abstract][Full Text] [Related]
9. [Construction and experimental immunity of recombinant replication-competent canine adenovirus type 2 expressing hemagglutinin gene of H5N1 subtype tiger influenza virus]. Gao YW; Xia XZ; Wang LG; Liu D; Huang G Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):297-300. PubMed ID: 16736595 [TBL] [Abstract][Full Text] [Related]
10. [Construction of a transfer vector based on canine adenovirus type-2]. Li Z; Zhang SF; Cui Y; Wang XH; Liu Y; Hu RL Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):319-22. PubMed ID: 17460909 [TBL] [Abstract][Full Text] [Related]
11. Canine adenovirus based rabies vaccines. Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509 [TBL] [Abstract][Full Text] [Related]
12. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Zhang S; Liu Y; Fooks AR; Zhang F; Hu R Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277 [TBL] [Abstract][Full Text] [Related]
13. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs. Yuan Z; Zhang S; Liu Y; Zhang F; Fooks AR; Li Q; Hu R Vaccine; 2008 Mar; 26(10):1314-21. PubMed ID: 18262313 [TBL] [Abstract][Full Text] [Related]
15. Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV. Yang S; Xia X; Qiao J; Liu Q; Chang S; Xie Z; Ju H; Zou X; Gao Y Vaccine; 2008 Mar; 26(11):1482-7. PubMed ID: 18313810 [TBL] [Abstract][Full Text] [Related]
16. [Recombinant replication-defective adenovirus based rabies vaccine]. Li WH; Zhang Y; Wang SH; Liu L; Yang F Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304 [TBL] [Abstract][Full Text] [Related]
17. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant. Zhang X; Zhang Y; Li W Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699 [TBL] [Abstract][Full Text] [Related]
18. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Liu Y; Zhang S; Ma G; Zhang F; Hu R Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839 [TBL] [Abstract][Full Text] [Related]
20. Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model. Lutze-Wallace C; Sapp T; Nadin-Davis SA; Wandeler A Can J Vet Res; 1992 Oct; 56(4):360-4. PubMed ID: 1477804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]